Application 212069
- Type
- ANDA
- Sponsor
- SANDOZ
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | VASOPRESSIN | VASOPRESSIN | SOLUTION;INTRAVENOUS | 200UNITS/10ML (20UNITS/ML) | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A212069-001 | VASOPRESSIN | VASOPRESSIN | 200UNITS/10ML (20UNITS/ML) | SOLUTION / INTRAVENOUS | AP | 2026-05-06 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A212069-001 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A212069-001 | VASOPRESSIN | 200UNITS/10ML (20UNITS/ML) | SOLUTION / INTRAVENOUS | AP | 2026-05-06 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A212069-001 | AP | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| VASOPRESSIN | VASOPRESSIN | HF Acquisition Co LLC, DBA HealthFirst | 53372911-5a55-dfac-e063-6394a90ae2f6 | 2026-07-21 | Warnings, Adverse reactions | VASOPRESSIN VASOPRESSIN |
| VASOPRESSIN | VASOPRESSIN | HF Acquisition Co LLC, DBA HealthFirst | 5232a8bc-d7ae-48a5-e063-6294a90a76ca | 2026-07-21 | Warnings, Adverse reactions | VASOPRESSIN VASOPRESSIN |
| VASOPRESSIN | VASOPRESSIN | HF Acquisition Co LLC, DBA HealthFirst | 52324969-4536-2b7c-e063-6394a90a9b4d | 2026-07-10 | Warnings, Adverse reactions | VASOPRESSIN VASOPRESSIN |
| Vasostrict | VASOPRESSIN | Par Health USA, LLC | b1147beb-743e-4c62-8927-91192447f8b8 | 2026-04-21 | Warnings, Adverse reactions | VASOPRESSIN |
| Vasostrict | VASOPRESSIN | Par Health USA, LLC | b97e5c3e-ca28-4ffa-80af-6c5bdbadaf10 | 2026-04-16 | Warnings, Adverse reactions | VASOPRESSIN |
| VASOPRESSIN | VASOPRESSIN | ProPharma Distribution | 386a8e67-1f18-6513-e063-6294a90a5ffe | 2025-12-18 | Warnings, Adverse reactions | VASOPRESSIN VASOPRESSIN |
| VASOPRESSIN | VASOPRESSIN | Eugia US LLC | eadd82d7-e2cb-4144-9f0c-b340f54c6fa4 | 2025-10-24 | Warnings, Adverse reactions | VASOPRESSIN VASOPRESSIN |
| Vasopressin | VASOPRESSIN | Gland Pharma Limited | 971f9b1c-6094-4f80-920b-cb5d7e62950a | 2025-08-26 | Warnings, Adverse reactions | Vasopressin VASOPRESSIN |
| VASOPRESSIN | VASOPRESSIN | HF Acquisition Co LLC, DBA HealthFirst | f5f03364-e71c-9bcd-e053-2995a90a8ada | 2025-07-11 | Warnings, Adverse reactions | VASOPRESSIN VASOPRESSIN |
| Vasopressin in 0.9% Sodium Chloride | VASOPRESSIN | Long Grove Pharmaceuticals, LLC | bf4b0b63-0055-40d8-b331-7f9f1ea3214c | 2025-06-17 | Warnings, Adverse reactions | VASOPRESSIN |
| vasopressin | VASOPRESSIN | Medical Purchasing Solutions, LLC | 3532868c-ac1d-43c8-e063-6394a90a4fd1 | 2025-05-15 | Warnings, Adverse reactions | vasopressin VASOPRESSIN |
| Vasopressin | VASOPRESSIN | Civica, Inc. | cce1a220-3178-49ec-b046-f0cb134cf051 | 2025-03-01 | Warnings, Adverse reactions | Vasopressin VASOPRESSIN |
| VASOPRESSIN | VASOPRESSIN | Fresenius Kabi USA, LLC | 50aef1e8-0a70-466d-93cd-c1b9ed489839 | 2025-02-27 | Warnings, Adverse reactions | VASOPRESSIN VASOPRESSIN |
| VASOPRESSIN | VASOPRESSIN | Fresenius Kabi USA, LLC | 04e0c406-6b49-4c0b-abc5-9a1a75532485 | 2025-02-15 | Warnings, Adverse reactions | VASOPRESSIN VASOPRESSIN |
| Vasopressin | VASOPRESSIN | Sagent Pharmaceuticals | ad3ac280-49da-4816-9097-14517d0c0f85 | 2024-11-09 | Warnings, Adverse reactions | Vasopressin VASOPRESSIN |
| Vasopressin | VASOPRESSIN | American Regent, Inc. | 0ab267f4-9ec9-44fd-8521-f975074667d9 | 2024-10-31 | Warnings, Adverse reactions | Vasopressin VASOPRESSIN |
| vasopressin | VASOPRESSIN | Dr. Reddy's Laboratories, Inc. | caf04d72-679e-daf9-e86f-4867f83b8ac5 | 2024-07-31 | Warnings, Adverse reactions | vasopressin VASOPRESSIN |
| vasopressin | VASOPRESSIN | Amneal Pharmaceuticals LLC | d9869345-b02c-4225-a97b-656f14c86dec | 2024-07-07 | Warnings, Adverse reactions | vasopressin VASOPRESSIN |
| VASOPRESSIN | VASOPRESSIN | Eugia US LLC | 85e3dc1e-98ae-4c4c-8af9-237375475e08 | 2023-11-07 | Warnings, Adverse reactions | VASOPRESSIN VASOPRESSIN |
| VASOPRESSIN | VASOPRESSIN | Medical Purchasing Solutions, LLC | 0933a550-03f1-0937-e063-6394a90a1e89 | 2023-11-02 | Warnings, Adverse reactions | VASOPRESSIN VASOPRESSIN |